Hepatitis C virus (HCV) infection is still a major cause of chronic liver diseases, with approximately 71 million chronically infected persons worldwide. People who inject drugs currently or in the past (PWID), mostly intravenously, are the main risk group among HCV chronically infected persons. The efficacy of therapy with direct-acting antivirals (DAA) is almost 100 %. Currently, the main mission is to diagnose HCV infection in the most possible number of infected persons; it is in collision with poor adherence of PWID in particular. Changing the spectrum of chronic hepatitis C patients forces medical professionals to change their approach to diagnosis and treatment of HCV infection. Outreach testing and cooperation with support organizations showed to be an effective way to set a course to eliminate HCV in the PWID population.

• Klíčová slova
• HCV elimination, chronic hepatitis C, outreach screening,
• MeSH
• antivirové látky terapeutické užití   MeSH
• časná diagnóza MeSH
• chronická hepatitida C * farmakoterapie   MeSH
• Hepacivirus MeSH
• hepatitida C * diagnóza   farmakoterapie   epidemiologie   MeSH
• intravenózní abúzus drog * farmakoterapie   epidemiologie   MeSH
• lidé MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• antivirové látky MeSH